Skip to Main Content

Find Case LawBeta

Judgments and decisions from 2001 onwards

Search results

How to search

Current filter(s)

From date

For example 01 01 2003 or 2003

To date

For example 30 04 2023 or 2023

From specific courts
From specific tribunals

For example a claimant, defendant or other party

For example Smith, or multiple judges: Smith, Jones

2,536 documents found

Results listing

  • Edwards Lifesciences LLC v Boston Scientific Scimed, Inc. & Ors High Court (Patents Court) [2017] EWHC 405 (Pat) Matching text sample:

    ...to claim 1 of each Patent, save for a brief...

    ...the construction of the 254 Patent required the distinction to be...

    ...identified the addressees of a patent specification thus (at p....

    Pfizer Ltd’s Patent

  • Generics (UK) Ltd & Ors v H Lundbeck A/S High Court (Patents Court) [2007] EWHC 1040 (Pat) Matching text sample:

    ...claims for revocation of European Patent (UK) No 0,347... ,066 (“The Patent”) in the name of...

    The Patent has a priority date of...

    ...to the validity of the Patent are founded upon the prior... ...pure (+) enantiomer. The Patent has seven claims of which...

    The attacks on the Patent can be summarised as follows...

  • Occlutech GmbH v Aga Medical Corp High Court (Chancery Division) [2009] EWHC 2013 (Ch) Matching text sample:

    This is a patent action in which the claimant... ...seeks the revocation of the patent on the grounds of obviousness... ...an application to amend the patent.

    The patent in suit

    The patent in suit concerns medical devices... ...in figure 5 of the patent which is reproduced in Appendix...

    ...revocation of the defendant’s patent, and for declaratory relief...

  • Sandoz Limited v Bristol-Myers Squibb Holdings Ireland Unlimited Company Court of Appeal (Civil Division) [2023] EWCA Civ 472 Matching text sample:

    ...determining the validity of a patent. This is a concept... ...mentioned in either the European Patent Convention or in the provisions... ...of Appeal of the European Patent Office in Case G 2...

    ...was the proprietor of European Patent (UK) No. 1... ...factor Xa inhibitors” (“the Patent”), which expired on... ...SPC”) based on the Patent, which expires on 19... ...2026. The claims of the Patent relate to a compound called... ...“Teva”) contend that the Patent is invalid, and therefore...

    ...the Claimants contend that the Patent is invalid because the specification... ...to the application for the Patent, published as WO 03/... ...that was only in the Patent and not in the Application... , the Patent would be invalid for added...

    The judge held that the Patent was invalid. BMS appeals... ...on the validity of the Patent and BMS does not pursue...

  • Illumina, Inc v Premaitha Health Plc High Court (Patents Court) [2017] EWHC 2930 (Pat) Matching text sample:

    ...relation to the Lo 1 Patent

    The Lo 1 Patent

    The Quake 1 Patent

    ...Claims of the Quake 1 Patent

  • Cinpres Gas Injection Ltd v Melea Ltd Court of Appeal (Civil Division) [2008] EWCA Civ 9 Matching text sample:

    ...about the ownership of European Patent (UK) No. 0,... ...invention the subject of the Patent. His task was made...

    The Patent is registered in the name... ...or purported title) to the patent from Ladney via another Ladney...

    ...to apply for a US patent. Thereafter international patent applications, claiming priority from...

    ...disputes not only for UK patent applications but for corresponding applications...

  • Kelly & Anor v GE Healthcare Ltd High Court (Patents Court) [2009] EWHC 181 (Pat) Matching text sample:

    of “patent” in section 40

    ...two patents (or more accurately patent families) involved in the... ...action. The first, European Patent (UK) No 0311352 (... ...1987. The second, European Patent (UK) No 0337654 (... ...are not the same everywhere. Patent protection continues in the United... ...inventors in respect of both patent families: Duncan Kelly, Ray...

    ...the employer for which a patent has been granted, that... the patent is (having regard among...

    a patent has been granted for an...

  • Les Laboratoires Servier & Anor v Apotex Inc & Ors High Court (Chancery Division) [2008] EWHC 2347 (Ch) Matching text sample:

    ...a prescription medicine. It obtained patent protection for the original compound... ...the product (“the 341 patent”). In July 2000... ...Servier applied for a further patent covering an allegedly new form... ...Form Alpha” (“the 947 patent”). By 2006 the... ...had expired, and the 947 patent was a second generation patent the object of which was... ...monopoly in Perindopril. The 947 patent was sought in the European... Patent Office and was the subject... ...practising the prior art 341 patent). On 27 July 2006... the European Patent Office dismissed this opposition and... held the 947 patent valid despite the earlier 341... patent. Servier was thereby placed...

    ...the process of the 341 patent. Apotex took the view... that the 947 patent was plainly invalid (since... ...product obtained by the 341 patent) and it was prepared... ...that opposition to the 947 patent had been dismissed by EPO...

    ...for the life of the patent, which in this case...

    ...held the 947 patent to be...

  • David Parsons v Convatec Limited High Court (Patents Court) [2023] EWHC 1535 (Pat) Matching text sample:

    ...the employer for which a patent has been granted,

    ...undertaking, the invention or the patent for it (or the...

    ...as amended) applies where a patent has been granted for an... ...and the rights in the patent or invention are subsequently assigned...

    the patent for the invention;

  • Regeneron Pharmaceuticals Inc v Kymab Ltd United Kingdom Supreme Court [2020] UKSC 27 Matching text sample:

    ...is a general requirement of patent law both in this country... and under the European Patent Convention (“EPC”) that... , in order to patent an inventive product, the... ...the teaching disclosed in the patent coupled with the common general... ...by the teaching in the patent.

    Patent protection is sometimes claimed for... ...range of products. Whether the patent claims one or the other... ...(or claims) in the patent. In the latter case... ...that the teaching in the patent did not enable any type...

    ...that the teaching in the patent, coupled with the available...

    ...is therefore whether a product patent, the teaching of which...